Genetic, Cellular and Molecular Aspects involved in Apical Periodontitis

Abstract

The development, establishment and repair of apical periodontitis (AP) is dependent of several factors, which include host susceptibility, microbial infection, immune response, quality of root canal treatment and organism's ability to repair. The understanding of genetic contributions to the risk of developing AP and presenting persistent AP has been extensively explored in modern Endodontics. Thus, this article aims to provide a review of the literature regarding the biochemical mediators involved in immune response signaling, osteoclastogenesis and bone neoformation, as the genetic components involved in the development and repair of AP. A narrative review of the literature was performed through a PUBMED/MEDLINE search and a hand search of the major AP textbooks. The knowledge regarding the cells, receptors and molecules involved in the host's immune-inflammatory response during the progression of AP added to the knowledge of bone biology allows the identification of factors inherent to the host that can interfere both in the progression and in the repair of these lesions. The main outcomes of studies evaluated in the review that investigated the correlation between genetic polymorphisms and AP in the last five years, demonstrate that genetic factors of the individual are involved in the success of root canal treatment. The discussion of this review gives subsides that may help to glimpse the development of new therapies based on the identification of therapeutic targets and the development of materials and techniques aimed at acting at the molecular level for clinical, radiographic and histological success of root canal treatment.

Key Words:
Pulp biology; apical periodontitis; bone remodeling process; host response; genetics

Resumo

O desenvolvimento, estabelecimento e reparo da periodontite apical (PA) depende de vários fatores, que incluem a susceptibilidade do hospedeiro, infecção microbiana, resposta imune, bem como a qualidade do tratamento do canal radicular e a capacidade de reparo do organismo. A compreensão das contribuições genéticas para o risco de desenvolver a PA e apresentar PA persistente tem sido extensivamente explorada na Endodontia moderna. Assim, este manuscrito pretende fornecer uma revisão da literatura em relação aos mediadores bioquímicos envolvidos na sinalização da resposta imune, osteoclastogênese e neoformação óssea, bem como os componentes genéticos envolvidos no desenvolvimento e reparo da PA. Uma revisão narrativa da literatura foi realizada através de uma pesquisa nas bases PUBMED/MEDLINE e uma pesquisa manual nos principais livros sobre a PA. O conhecimento sobre as células, receptores e moléculas envolvidas na resposta imuno-inflamatória do hospedeiro durante a progressão da PA somado ao conhecimento da biologia óssea, especialmente o papel dos osteoblastos, osteócitos e osteoclastos no turnover ósseo, permite a identificação de fatores inerentes ao hospedeiro que podem interferir tanto na progressão como no reparo destas lesões. Os principais resultados dos estudos avaliados na revisão que investigaram a correlação entre polimorfismos genéticos e PA, nos últimos cinco anos, demonstram que os fatores genéticos do indivíduo estão envolvidos no sucesso do tratamento do canal radicular. A discussão desta revisão fornece subsídios que podem ajudar a vislumbrar o desenvolvimento de novas terapias baseadas na identificação de alvos terapêuticos e no desenvolvimento de materiais e técnicas destinadas a atuar a nível molecular para o sucesso clínico, radiográfico e histológico do tratamento endodôntico.

Introduction

When microorganisms infect dental mineralized tissues, the components of the immune system recognize these invading microorganisms as non-self ¹, consequently an inflammatory process is established in the pulp tissue, which results in the recruitment of chronic inflammatory cells, that involves the recruitment and activation of different cell types to fight the infection. In cases of this stimulus remains persistent, the pulp tissue evolves to necrosis, with subsequent resorption of mineralized tissues, resulting in the formation of a periapical osteolytic lesion ².

Root canal treatment aims to eliminate the infection of the root canal system (RCS), through the neutralization of the aggressive agents of bacterial origin, by use of an adequate biomechanical preparation protocol, including the use of irrigating solutions and intracanal medication ^3,4. Thus, after the cleaning and shaping of root canals, the disinfection of the RCS is reached, and tridimensional filling should be performed, in order to provide the repair of periapical tissues and success of the treatment.

However, the presence of apical periodontitis (AP) is associated with a higher failure rate after root canal treatment ^5,6,7,8. This rate is dependent on different factors, once the anatomic complexity of the RCS, in addition to the location of the apical foramen, may hinder the complete disinfection ^4,7,9. Moreover, the host immune system plays an important role in trying to eliminate the aggressive agent present in areas inaccessible to biomechanical preparation.

In some situations, it is possible to eliminate the aggressor agent by means of the immune and inflammatory responses triggered to neutralize/destroy these agents, resulting in the resolution of AP ¹⁰. However, in other situations, due to unsatisfactory host defense to infection present in root canals ¹¹,¹², or following exacerbated and persistent activation of the host innate and adaptive immune system, AP remains persistent to root canal treatment ¹³. Yet, there are several host genetic components involved in the establishment, progression and repair of AP ¹⁴. Thus, this article aims to provide a review of the literature regarding these components associated with the biochemical mediators involved in the signaling in the immune response, osteoclastogenesis and bone neoformation, during the development and repair of AP.

Influence of genetics on apical periodontitis

Considering the differences in the human DNA sequence, not all individuals have the same response to a certain stimulus or treatment due to differences in the human DNA sequence, which influence the organism's susceptibility to disease and its responses to the environment ^15,16. These variations are considered normal but when found in more than 1% of the population are called genetic polymorphisms ^15,17,18,19.

When there is a substitution of one nucleotide for another, occurring the exchange of a base pair, they are called single nucleotide polymorphisms (SNPs), which are the most common type of polymorphism. This exchange can still affect protein expression, structure and function of a gene ²⁰. Thus, genetic variations caused by mutations or genetic polymorphisms may influence host response.

Both genetic polymorphisms and mutations can be located in various regions of the gene, such as the promoter region, coding region (exons) and non-coding region (introns). In general, genetic variations in the promoter and coding region are more likely to modify the function of the gene and consequently alter protein formation. Changes in the coding region may, for example, lead to an amino acid substitution in the protein sequence, which may cause structural and functional modifications in the protein and a potential biological effect. Thus, genetic polymorphisms can alter protein synthesis and cellular function, which may affect the progression of AP ^20,22,23.

Considering that, AP is a multifactorial disease ²⁴ from the polymicrobial origin and represents a localized immunoinflammatory response, characterized by the presence of a mixed inflammatory infiltrate ^{25,26,27,28,29}, the investigation of the interaction between molecular signals, genetic influence and clinical signs of AP is a promisor topic of research.

In recent years, interactions between genetic polymorphisms and the development, progression and repair of AP have been evidenced in genes linked to inflammation and bone metabolism processes ^{23,30,31,32,33,34,35,36,37,38,39,40,41,42,43,44,45,46,47,48,49,50}, which are represented at Figure 1. Thus, there is an important discussion of these molecular aspects involved in the etiopathogenesis of dental caries, AP and repair after root canal treatment, which will be addressed throughout the next topics.

Figure 1
Representation of cellular, molecular components and mediators linked to inflammation and bone metabolism processes that were evaluated regarding the influence of genetic polymorphisms in the development, progression and repair of apical periodontitis. Cytokines (IL-1β, -4, -6, -8, -10, -12, -17, TNF-α, INF-γ) and macrophage migration inhibitory factor (MIF) are intimately related to the macrophage’s activity. RANK, RANKL, OPG are main controllers of the bone metabolism process. RUNX2, SMAD6 are transcriptional factors of osteoblast activity. BMPs, MMPs, TIMPs are proteins secreted into the extracellular media. DEFB1 is a defensine secreted by neutrophils. HIF1A gene encodes the alpha subunit of transcription factor HIF-1a, which regulates oxygen dependent gene transcription. VDR is recognized as a member of the super-family of nuclear receptors that regulate genes expression and has a central role in the biology of vitamin D action. WNT, TBX21 and TP63 comprehends respectively, signaling pathway, a gene involved in the activity of lymphocytes, a gene that encodes a TP63 protein, which controls the cell activity.

Cellular and molecular components on apical periodontitis development

The localized, destructive and progressive infection of mineralized tissues of the tooth, dental caries, when untreated can result in implications for the dental pulp ¹³, which is a specialized connective tissue, richly vascularized and innervated, of ectomesenchymal origin, that presents sensory, protective, inductive, formative and nutritive functions ⁵¹.

In response to infection in the dental pulp and periapical tissues, activation of innate immune system cells occurs locally ⁵². The cells of the innate immune system possess receptors that recognize pathogen-associated molecular patterns (PAMPs), which includes bacterial components such as lipopolysaccharide (LPS) and lipoteichoic acid (LTA) ⁵³. Through this pattern recognition receptors (PRRs), among which Toll-like receptors (TLRs) are prominent, cells are able to respond to pathogen invasion. TLRs are type I transmembrane proteins ⁵⁴ and have been identified, in humans, expressing TLRs 1 to 10 and, in mice, expressing TLRs 1 to 9 and 11 to 13 ⁵⁵.

After the activation of pathogen recognition receptors and the expression of intra- and extracellular biochemical mediators, the activation of different cell types occurs. As part of the immune-inflammatory response, neutrophils, macrophages, lymphocytes, plasma cells, dendritic cells and natural killer cells are recruited to the site of inflammation in order to eliminate the aggressor agent ^2,24,25,56. This action is coordinated and regulated by the release of cytokines, chemokines, growth factors, extracellular matrix components and other bioactive molecules ^2,27,57,58.

Initially, upon encountering pathogens, tissue macrophages stimulate an inflammatory process via the release of cytokines and chemokines, resulting in the recruitment and activation of other cells, such as neutrophils and monocytes ^59,60. Macrophages are phagocytic cells of innate immunity and, together with neutrophils, provide the first line of defense against the microorganism ⁵⁹. Macrophages attempt to prevent the invasion of these agents through phagocytosis, secretion of lytic enzymes and activation of the complement system ^59,60. In addition to their phagocytic function, macrophages act as antigen-presenting cells to lymphocytes, mediating adaptive immunity ⁵⁶.

With the progression of AP, there is an infiltration of cellular elements of adaptive immunity, including the participation of B and T lymphocytes ^2,27,52. Lymphocytes, which express antigen-specific receptors, represent the key cells of the adaptive immune system and originate from bone marrow precursors to differentiate into mature effector cells in the periphery. B-lymphocytes recognize antigen by their cellular receptor BCR and produce different antibodies. T lymphocytes have the TCR receptor that recognizes antigen by means of molecules expressed on the cell surface, known as major histocompatibility complex.

In addition to cellular recruitment, during the inflammatory response, several biochemical mediators are released locally with the aim of stimulating the cellular and humoral immune response. Among these inflammatory mediators are the eicosanoids, which are synthesized from the metabolism of arachidonic acid, produced by the action of phospholipase enzymes. Through the action of cyclooxygenases (COX) or lipoxygenases (LO) enzymes, structural modifications occur in the arachidonic acid chain, leading to the synthesis of prostaglandins and thromboxanes or leukotrienes and lipoxins, respectively ^61,62. Prostaglandins increase local blood flow, vascular permeability and edema formation, and amplify the pattern of the inflammatory response, to promote both the increase and prolongation of the effects and signals produced by pro-inflammatory agents ⁶¹. Leukotrienes have important biological functions, including an efficient chemotactic action, aggregation and degranulation of polymorphonuclear cells, as well as stimulating leukocyte adherence to the endothelial wall for transmigration of inflammatory cells ^63,64.

Pro- and anti-inflammatory cytokines are also important signalers for host defense. Cytokines function as messengers and represent a family of glycoproteins that coordinate biological processes such as embryonic development, immunity, hematopoiesis and repair ^65,66,67. The pro-inflammatory cytokines include the interleukins (IL) -1α, -1β, -6, -8, and the tumor necrosis factor-alpha (TNF-α), among others ⁶⁸. Interleukins, particularly IL-1α and IL-1β, are produced in AP by different cell types including macrophages, osteoclasts, polymorphonuclear cells and fibroblasts ^69,70. The local effects of IL-1β consist of increased leukocyte adhesion to endothelial walls, stimulation of lymphocytes, potentiation of neutrophils, production of prostaglandins and proteolytic enzymes, increased bone resorption and inhibition of bone formation ^71,72. IL-6 is produced under the influence of IL-1β, TNF-α and interferon-γ (INF-γ), acting as a negative regulator of production and antagonizing the effects of IL-1β ⁷³. The production of IL-8 is carried out by monocytes, macrophages and fibroblasts under the influence of IL-1β and TNF-α ⁷⁴, which, being a chemo-attractant, is of paramount importance in the acute phase of AP, in which a massive infiltration of neutrophils occurs ²⁵.

IL-22 is a cytokine belonging to the IL-10 family ⁷⁵ and expressed by different types of lymphocytes from both the innate and adaptive immune systems. This includes CD4 T cell subsets, most notably Th17 cells ^76,77. In addition, this is the main effector cytokine of Th22 helper T cells ⁷⁸. IL-22 contributes to the expression of several molecules encoding genes involved in the inflammatory response including IL-6, G-CSF (granulocyte colony-stimulating factor) and IL-1α ^79,80. This cytokine has been shown to act on hepatocytes, epithelial cells, keratinocytes and fibroblasts, inducing in vitro and in vivo an acute phase response and stimulation of the release of chemokines and matrix metalloproteinases ^81,82,83.

Cytokines act on different signaling networks and it has been described that TNF- α, IL-17, IFN-γ and IL-1β influence some effects of IL-22 ⁷⁹. It is worth noting that T cells differentiate towards the Th22 phenotype in the presence of some cytokines, such as TNF-α and IL-6 ⁸⁴ and, in the presence of IL-1β and IL-6, differentiate towards the Th17 phenotype ⁷⁷. The dual nature of this response, sometimes synergistic and sometimes antagonistic, played by IL-22 is related to the inflammatory context, which includes the duration and accumulation of the cytokine, the global cytokine milieu and the type of tissue involved ⁷⁶. IL-22 may also act synergistically with several other cytokines, including IL-17A, IL-17B and TNF-α ^77,85. Co-secretion of IL-22 with pro-inflammatory agents such as TNF-α, IFN-γ and/or IL-17 results in a significant increase in the immune-inflammatory reaction, whereas IL-22 alone has a protective and regenerative effect ⁸⁶. For the above, in experimental AP, it was demonstrated that IL-22 clearly modifies the pattern of the inflammatory response and the absence of this cytokine resulted in a smaller extension of lesions and a reduction in the number of osteoclasts, especially in late periods when a chronic inflammatory infiltrate is prevalent ⁸⁷.

As a way of controlling the immune response, the host cells have a mechanism to inhibit the exacerbated production of pro-inflammatory cytokines. This process happens by cytokine signaling suppressor proteins called SOCS-1, SOCS-2 and SOCS-3 ^65,66,88,89. SOCS-1 is activated by the presence of INF-γ, TNF-α, IL-6, or even by exposure to bacterial lipopolysaccharide, and its action occurs by inhibition of the expression of the same INF-γ, TNF-α and IL-6 ^65,66,88. SOCS-3, in general, acts on the expression of IL-1, IL-6, IL-10 and INF-γ ^65,66 and has been found in periapical granulomas, together with the expression of IL-10 ⁸⁹. Added to this, it is known that SOCS-3 expression is induced by pro-inflammatory cytokines and this condition inhibits the secretion of chemokines induced by IL-1β or IL-6. SOCS-3 protein expression in humans plays important negative feedback, suppressing AP progression ⁹⁰. These proteins have been found in bone diseases ⁹¹, periodontal disease ^92,93 and AP ^89,90,94, suggesting an important defense mechanism of the body in combating exacerbated inflammation and bone loss.

Mediators involved in the resorption of mineralized tissues

The main players involved in the resorption process of bone and tooth structures are known as canonical mediators of osteoclastogenesis and include the nuclear factor activating receptor NF-kB (RANK), RANK ligand (RANKL) and osteoprotegerin (OPG) ^95,96. RANK is a receptor found on the surface of clastic cells acting in cell differentiation. RANKL is a soluble ligand synthesized by osteoblasts and osteocytes and cells of the immune system and, when bound to the RANK receptor, induces the expression of genes that specify the osteoclast lineage such as the enzyme tartrate-resistant acid phosphatase (TRAP), matrix metalloproteinase-9 (MMP-9), cathepsin K and the receptor for calcitonin, as well as differentiation, maturation and activation of osteoclasts to stimulate resorption of mineralized tissues ^95,97. RANKL induces osteoclast maturation and activity ⁹⁵. OPG, on the other hand, is a soluble receptor binds to RANKL and inhibits osteoclast differentiation and activity. The imbalance in RANKL and OPG expression in inflammatory conditions, in which there is increased RANKL and decreased OPG activity, results in exacerbated osteoclastogenesis and bone resorption ^2,89,98.

The cellular component of bone tissue is comprised of osteoblasts, surface or lining cells (lining cells), osteoclasts and osteocytes. Among these cell types, osteocytes represent more than 95% of the cells present and increase in number according to the age and size of the bone ^99,100, while osteoblasts correspond to less than 5% and osteoclasts to less than 1% ¹⁰¹. Osteocytes remain viable for decades, whereas osteoblasts survive for weeks and osteoclasts for days ^99,102.

Thus, another important mechanism in the process of bone remodeling occurs via signaling by osteocytes. These cells participate in bone formation through the expression of proteins such as type I collagen and osteocalcin in addition to proteins involved in the mineralization of this tissue such as alkaline phosphatase ¹⁰³. Moreover, the effect of osteocytes on bone formation is related to their interference in the Wnt/β-catenin complex, one of the most important signaling pathways responsible for the regulation of osteoblast function ^103,104.

In root canal infection, microorganisms and their by-products stimulate the local inflammatory response and intense production of proteases that degrade the extracellular matrix and facilitate the resorption process of mineralized tissues, both bone and teeth ^105,106,107. Among the proteases are the matrix metalloproteinases (MMPs), an important family of metallopeptidases, capable of degrading components of the extracellular matrix (ECM), including the organic portion of the bone. Members of the MMP family are divided into collagenases (MMP-1, -8 and -13), gelatinases (MMP-2 and -9), stromelysins (MMP-3 and -10), membrane MMPs (MMP-14, -15, -16, -17 and -24) and others (MMP-7, -12, -19, -20, -21, -22 and -23) ¹⁰⁸. MMPs are synthesised as latent enzymes that may be present inside inflammatory cells, but are most often membrane-bound or embedded in the extracellular matrix ^109,110.

In parallel to the disorganization of the collagen matrix in AP, resorption of inorganic mineralized tissue also occurs from osteoclastogenesis. In this process, monocytes coming from the circulation are recruited by macrophage colony-stimulating factor (M-CSF), fuse and form osteoclasts, differentiated cells specialized in the process of degradation of bone matrix components ^111,112. Osteoclasts, characterized as multinucleated giant cells, present in their membrane calcitonin receptor, and are positive for the enzyme tartrate-resistant acid phosphatase (TRAP) ^111,112,113.

The immune response generated against bacteria or by-products, although it is a defense response, may lead to different degrees of injury to the organism. In inflammation near bone tissue, for example, there is a close relationship between the mediators of the inflammatory response and the metabolism of mineralized tissue. In periapical injury, pro-inflammatory cytokines stimulate the resorption process and inhibit bone neoformation ^2,114. On the other hand, anti-inflammatory cytokines are responsible for coordinating the activity of inflammatory cells aiming at repair. In vivo studies with genetically modified animals deficient in different receptors and cytokines confirm the relationship between the expression of anti- and pro-inflammatory cytokines associated with AP progression and osteoclastogenesis induction ^87,115,116.

The increased synthesis of prostaglandin E2 in teeth with periapical inflammation is related to inflammatory and catabolic (pro-resorptive) changes that occur in AP ¹¹⁷ and the decreased production of this lipid mediator may be an indication of disease remission ¹¹⁸. TNF-⍺ plays an important role in the inflammatory response of pulp tissue and AP development ^119,120. It is a cytokine stimulated by monocytes/macrophages, polymorphonuclear neutrophils and fibroblasts ²⁵ and has the ability to stimulate a group of cytokines called chemokines, whose chemotactic action assists in fighting the infectious process ¹²¹. On the other hand, TNF-⍺ regulates the synthesis of bone matrix protein, increases the production of interleukin-6 and macrophage stimulating factor (M-CSF) by osteoblasts, and indirectly promotes the differentiation of osteoclasts ¹²². In an animal model, gene expression analysis showed a positive correlation between MyD88-RANKL and TLR2-MyD88 expression, indicating the relevance of the immune response in bone loss arising from intra-canal bacterial infection ¹²³.

Similarly, on the tooth surface, during the process of resorption of dentin and cementum, the presence of dentinoclasts and cementoclasts from the monocytic lineage is observed and present functions similar to those of osteoclasts ^121,123. This group of cells are collectively known as clasts because they exert similar physiological or pathological activities according to the tissue they absorb, since there is no structural, organizational and functional difference between these cells ¹¹².

Influence of genetic polymorphisms on apical periodontitis repair: data from literature

The persistence of AP, after root canal treatment, may be related to different factors, including aspects of the quality of root canal treatment, such as presence of root perforations, instrument fractures and quality of root canal filling, as well as the non-effective removal of microorganisms and their by-products from the RCS, including the external root surface in the form of biofilm ¹²⁴. It is also noteworthy that, in addition of aspects of the biomechanical preparation, the host response against the pathogenic potential of microorganisms and their susceptibilities to antimicrobials commonly used in Endodontics has been studied as one of the factors that define success or failure after root canal treatment ^{28125,126,127,127}.

In recent years, understanding the genetic contributions to the risk of developing AP and the risk of presenting persistent AP has been investigated ^{16,30,31,32,33,34,35,36,37,38,39,40,41,42,43,44,45,46,47,48,49,50}, since genetic polymorphisms may be biological modifiers of individual susceptibility in the development and course of diseases, including AP ¹². AP is a multifactorial disease, in which some factors such as genetic polymorphisms and epigenetic factors could be involved in persistent AP after root canal treatment ¹²⁸. Considering its multifactorial characteristics, this disease must be treated with an approach to the microbiology, quality of treatment and host response particularities ⁴¹.

From this, we performed a review of the literature, regarding the influence of genetic components on AP. The search strategy included the terms “genetic polymorphisms” AND “apical periodontitis”, was performed in October 2021, on PUBMED/MEDLINE database, and only studies written in English were selected. The inclusion criteria include studies that evaluated the association between genetic polymorphisms with the development, persistence and clinical signs and symptoms of AP, performed in the last five years. From a total of 46 studies, 14 were included and their main outcomes were represented in Figure 2.

Figure 2
Studies that investigated the correlation between genetic polymorphisms and apical periodontitis, in the last five years: genes evaluated and main outcomes.

The differences in the outcomes obtained by these studies, is explained by the fact that functional effects of genetic polymorphisms are dependent of the region of the gene that occurs the exchange of a base pair ^15,20,21,22. The SNPs in the coding region of gene are divided into two types: synonymous and nonsynonymous SNPs. The synonymous SNPs do not change the amino acid sequence of protein or not affect the protein function. The nonsynonymous SNPs are divided into two types: missense and nonsense. A missense SNP, arise in the coding region that alters the amino acid configuration which may have impact on structure and function of protein ¹²⁹. For nonsense, a point mutation in a sequence of DNA that changes to a stop codon results in a nonfunctional protein product. Besides that, SNPs that are in non-coding regions of gene or in the intergenic regions may affect gene splicing (SNPs at intron region), transcription factor binding (SNPs at 5′ untranslated region), messenger RNA degradation, or the sequence of non-coding RNA. The type of SNPs located upstream or downstream from the gene that affects gene expression is referred to an expression SNP (eSNP). Thus, in the evaluated studies, while some genetic polymorphisms were associated with a higher risk to develop persistent AP, others have protective role.

It is noteworthy that these studies are still controversial regarding methodological and sampling variables, from the point of view of disease, treatment, and ethnic and individual factors ^14,130. The pleiotropic effect of genetic polymorphisms may explain part of the associations observed in epidemiological studies between AP and different systemic alterations, such as metabolic syndrome ^131,132, ischemic heart disease ¹³³ and diabetes ¹³⁴. Additionally, a recent review emphasized the need for further studies within new cohorts of different populations and ethnicities to either confirm or refute the role of genetic polymorphisms in AP ¹³⁵. However, despite the controversies and the small number of studies that evaluated the role of genetic polymorphisms in the response of patients to root canal therapy, the existing results clearly demonstrate that genetic factors of the individual are involved in the success of root canal treatment. Further longitudinal studies are required to replicate the data obtained in these studies and to analyze gene expression, synthesis and protein activity of pro- and anti-inflammatory cytokines involved in the etiopathogenesis and repair of chronic AP, this may help to glimpse the development of new therapies, materials and techniques.

Conclusions

Genetic polymorphisms in genes related to the host immune response, as well as genes involved in bone repair mechanisms, are involved in the individual's response to treatment and may in the future serve as biomarkers in clinical practice. Moreover, the knowledge regarding the cells, receptors and molecules involved in the host's immune-inflammatory response during the progression of AP added to the knowledge of bone biology, especially the role of osteoblasts, osteocytes and osteoclasts in bone turnover allows the identification of factors inherent to the host that can interfere both in the progression and in the repair of these lesions. This may help to glimpse the development of new therapies based on the identification of therapeutic targets and the development of materials and techniques aimed at acting at the molecular level for clinical, radiographic and histological success of root canal therapy.

Acknowledgments

We acknowledge with thanks, the financial support provided by the Coordination for the Improvement of Higher Education Personnel (CAPES, Brazil, No.33002029032P4) and São Paulo Research Foundation(FAPESP, Brazil, 2010/17611-4; 2013/09595-7; 2015/06866-5). The authors deny any conflicts of interest related to this study.

References

• ¹
  Takeda, K; Akira, S. Toll-like receptors in innate immunity. Int Immunol. 2005; 17(1):1-14.
• ²
  Graves DT; Oates T; Garlet GP. Review of osteoimmunology and the host response in endodontic and periodontal lesions. J Oral Microbiol2011: 3.
• ³
  Siqueira JF Jr; Rôças IN. Clinical implications and microbiology of bacterial persistence after treatment procedures. J Endod. 2008; 34(11): 1291-1301.
• ⁴
  Sousa-Neto MD; Silva-Sousa YC; Mazzi-Chaves JF; Carvalho K; Barbosa A; Versiani MA; et al. Root canal preparation using micro-computed tomography analysis: a literature review. Braz Oral Res. 2018; 32(1): 20-43.
• ⁵
  Nair PN; Sjögren U; Krey G; Sundqvist G. Therapy-resistant foreign body giant cell granuloma at the periapex of a root-filled human tooth. J Endod. 1990;16(12):589-95.
• ⁶
  Siqueira JF, Jr; Rôças, IN. Polymerase chain reaction-based analysis of microorganisms associated with failed endodontic treatment. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2004;97(1):85-94.
• ⁷
  Estrela, C; Holland, R; Estrela, CR; Alencar, AH; Sousa-Neto ,MD; Pécora, JD. Characterization of successful root canal treatment. Braz Dent J. 2014;25(1):3-11.
• ⁸
  Silva, LABD; Sá, MAR; Melo, RA; Pereira ,JDS; Silveira, ÉJDD Miguel, MCDC. Analysis of CD57+ natural killer cells and CD8+ T lymphocytes in periapical granulomas and radicular cysts. Braz Oral Res. 2017;18;31:e106.
• ⁹
  Siqueira Junior, JF; Rôças, IDN; Marceliano-Alves, MF; Pérez, AR; Ricucci, D. Unprepared root canal surface areas: causes, clinical implications, and therapeutic strategies. Braz Oral Res. 2018;32(1).
• ¹⁰
  Van Bodegom, D; May, L; Meij, HJ; Westendorp, RG. Regulation of human life histories: the role of the inflammatory host response. Ann N Y Acad Sci. 2007;1100:84-97.
• ¹¹
  Orstavik, D. Time-course and risk analyses of the development and healing of chronic apical periodontitis in man. Int Endod J. 1996;29(3):150-5.
• ¹²
  Kandaswamy, D; Venkateshbabu, N. Root canal irrigants. J Conserv Dent. 2010;13(4):256-64.
• ¹³
  Cohen, S.; Hargreaves, K.M. Caminhos da Polpa (translation of Pathways of the pulp) (2007). 10 ed. Rio de Janeiro: Elsevier.
• ¹⁴
  Aminoshariae, A; Kulild, JC. Association of Functional Gene Polymorphism with Apical Periodontitis. J Endod. 2015;41(7):999-1007.
• ¹⁵
  Shastry, BS. SNP alleles in human disease and evolution. J Hum Genet. 2002;47(11):561-6.
• ¹⁶
  Souza, LC; Crozeta, BM; Guajardo, L; Brasil da Costa, FH; Sousa-Neto, MD; Letra, A; et al. Potential role of TP63 in apical periodontitis development. Int Endod J. 2019;52(9):1344-53.
• ¹⁷
  Brookes AJ. The essence of SNPs. Gene. 1999;234(2):177-86.
• ¹⁸
  Sachidanandam, R; Weissman, D; Schmidt, SC; et al. A map of human genome sequence variation containing 1.42 million single nucleotide polymorphisms. Nature. 2001;409(6822):928-33.
• ¹⁹
  Balasubramanian, SP; Cox, A; Brown, NJ; Reed, MW. Candidate gene polymorphisms in solid cancers. Eur J Surg Oncol. 2004;30(6):593-601.
• ²⁰
  Takashiba, S; Naruishi, K. Gene polymorphisms in periodontal health and disease. Periodontol 2000. 2006;40:94-106.
• ¹²
  Wan, M; Shi, X; Feng, X; Cao, X. Transcriptional mechanisms of bone morphogenetic protein-induced osteoprotegrin gene expression. J Biol Chem. 2001;276(13):10119-25.
• ²²
  Yoshie, H; Kobayashi, T; Tai, H; Galicia JC. The role of genetic polymorphisms in periodontitis. Periodontol 2000. 2007;43:102-32.
• ²³
  Siqueira JF, Jr; Rôças, IN; Provenzano, JC; Guilherme, BP. Polymorphism of the FcγRIIIa gene and post-treatment apical periodontitis. J Endod. 2011;37(10):1345-8.
• ²⁴
  Stashenko, P; Yu, SM; Wang, CY. Kinetics of immune cell and bone resorptive responses to endodontic infections. J Endod. 1992;18(9):422-6.
• ²⁵
  Nair, PN. Pathogenesis of apical periodontitis and the causes of endodontic failures. Crit Rev Oral Biol Med. 2004;15(6):348-81.
• ²⁶
  Paula-Silva, FW; Ghosh, A; Arzate, H; Kapila, S; da Silva, LA; Kapila YL. Calcium hydroxide promotes cementogenesis and induces cementoblastic differentiation of mesenchymal periodontal ligament cells in a CEMP1- and ERK-dependent manner. Calcif Tissue Int. 2010;87(2):144-57.
• ²⁷
  Márton, IJ; Kiss, C. Overlapping protective and destructive regulatory pathways in apical periodontitis. J Endod. 2014;40(2):155-63.
• ²⁸
  Siqueira JF, Jr; Rôças, IN; Ricucci, D; Hülsmann, M. Causes and management of post-treatment apical periodontitis. Br Dent J. 2014;216(6):305-12.
• ²⁹
  Figueiredo, J; Machado, AM; Oliveira, VP; Hartmann, R; Waltrick, S; Borba, MG; et al. Dendritic cells and their relation to apical peridontitis. Braz Oral Res. 2018;32(suppl 1):e71.
• ³⁰
  Siqueira, JF Jr; Rôças, IN. Diversity of endodontic microbiota revisited. J Dent Res. 2009;88(11):969-81.
• ³¹
  Morsani, JM; Aminoshariae, A; Han, YW; Montagnese, TA; Mickel, A. Genetic predisposition to persistent apical periodontitis [published correction appears in J Endod. 2011 Jun;37(6):887]. J Endod. 2011;37(4):455-9.
• ³²
  Menezes-Silva, R; Khaliq, S; Deeley, K; Letra, A; Vieira AR. Genetic susceptibility to periapical disease: conditional contribution of MMP2 and MMP3 genes to the development of periapical lesions and healing response. J Endod. 2012;38(5):604-7.
• ³³
  Amaya, MP; Criado, L; Blanco, B; et al. Polymorphisms of pro-inflammatory cytokine genes and the risk for acute suppurative or chronic nonsuppurative apical periodontitis in a Colombian population. Int Endod J. 2013;46(1):71-8.
• ³⁴
  Rôças, IN; Siqueira JF Jr; Del Aguila, CA; Provenzano, JC; Guilherme, BP; Gonçalves, LS. Polymorphism of the CD14 and TLR4 genes and post-treatment apical periodontitis. J Endod. 2014;40(2):168-72.
• ³⁵
  Dill, A; Letra, A; Chaves de Souza, L; et al. Analysis of multiple cytokine polymorphisms in individuals with untreated deep carious lesions reveals IL1B (rs1143643) as a susceptibility factor for periapical lesion development. J Endod. 2015;41(2):197-200.
• ³⁶
  Evrosimovska, B; Dimova, C; Popovska, L; Zabokova-Bilbilova E. Matrix Matalloproteinase-8 Gene Polymorphism in Chronic Periapical Lesions. Pril (Makedon Akad Nauk Umet Odd Med Nauki). 2015;36(2):217-24.
• ³⁷
  Maheshwari, K; Silva, RM; Guajardo-Morales, L; Garlet GP; Vieira AR; Letra A. Heat Shock 70 Protein Genes and Genetic Susceptibility to Apical Periodontitis. J Endod. 2016;42(10):1467-71.
• ³⁸
  Salles, AG; Antunes, LAA; Carvalho, PA; Küchler, EC; Antunes ,LS. Association Between Apical Periodontitis and TNF-α -308 G>A Gene Polymorphism: A Systematic Review and Meta-Analysis. Braz Dent J. 2017;28(5):535-42.
• ³⁹
  Salles, AG; Antunes, LAA; Küchler, EC; Antunes, LS. Association between Apical Periodontitis and Interleukin Gene Polymorphisms: A Systematic Review and Meta-analysis. J Endod. 2018;44(3):355-62.
• ⁴⁰
  Mazzi-Chaves, JF; Petean, IBF; Soares, IMV; Salles, AG; Antunes, LA; Segato, RA; et al. Influence Of Genetic Polymorphisms In Genes Of Bone Remodeling And Angiogenesis Process In The Apical Periodontitis. Braz Dent J. 2018;29(2):179-83.
• ⁴¹
  Petean, IBF; Küchler, EC; Soares, IMV; Segato,, RAB; Silva LAB; Antunes, LA; et al. (2019). Genetic Polymorphisms in RANK and RANKL are Associated with Persistent Apical Periodontitis. J Endod.45(5):526-31.
• ⁴²
  De Souza, LC; Cavalla, F; Maili, L; Garlet GP ; Vieira AR ; Silva RM; et al. WNT gene polymorphisms and predisposition to apical periodontitis. Sci Rep. 2019;9(1):18980.
• ⁴³
  Colavite, PM; Cavalla, F; Garlet, TP; Azevedo, MCS; Melchiades, JL; Campanelli, AP; et al. TBX21-1993T/C polymorphism association with Th1 and Th17 response at periapex and with periapical lesions development risk. J Leukoc Biol. 2019;105(3):609-19.
• ⁴⁴
  Freer-Rojas, A; Martínez-Garibay, LC; Torres-Méndez, F; Dávila-Pérez, CE; Martínez-Castañón, GA; Patiño-Marín, N; et al. Macrophage migration inhibitory factor gene polymorphisms as exacerbating factors of apical periodontitis. Adv Clin Exp Med. 2020;29(5):597-602.
• ⁴⁵
  Silva-Sousa, AC; Mazzi-Chaves, JF; Freitas, JV; Salles, AG; Segato, RABS; Silva, LAB; et al. Association between Estrogen, Vitamin D and Microrna17 Gene Polymorphisms and Periapical Lesions. Braz Dent J. 2020;31(1):19-24.
• ⁴⁶
  Torres, AFC; Antunes ,LS; Oliveira, NF; Küchler, EC; Gomes, CC; Antunes, LAA. Genetic Polymorphism and Expression of Matrix Metalloproteinases and Tissue Inhibitors of Metalloproteinases in Periapical Lesions: Systematic Review. J Endod. 2020;46(1):3-11.e1.
• ⁴⁷
  Jakovljevic, A; Nikolic, N; Carkic, J; Beljic-Ivanovic, K.; Soldatovic, I.; Mileticet al. Association of polymorphisms in TNF-α, IL-1β, GSTM and GSTT genes with apical periodontitis: is there a link with herpesviral infection?. Int Endod J. 2020;53(7):895-904.
• ⁴⁸
  Jakovljevic, A; Nikolic, N; Jacimovic, J; Miletic, M; Andric, M; Milasin, J. et al. Tumor Necrosis Factor Alpha -308 G/A Single-Nucleotide Polymorphism and Apical Periodontitis: An Updated Systematic Review and Meta-analysis. J Endod. 2021; 47(7),1061-1069.
• ⁴⁹
  Antunes, LS; Carvalho, L; Petean, IBF; Antunes, LA; Freitas, JV; Salles, AG; et al. Association between genetic polymorphisms in the promoter region of the defensin beta 1 gene and persistent apical periodontitis. Int Endod J. 2021;54(1):38-45.
• ⁵⁰
  Küchler, EC; Hannegraf, ND; Lara, RM; Reis, CLB; Oliveira ,DSB; Mazzi-Chaves, JF; et al. Investigation of Genetic Polymorphisms in BMP2, BMP4, SMAD6, and RUNX2 and Persistent Apical Periodontitis. J Endod. 2021;47(2):278-285.
• ⁵¹
  Glossary of Endodontic Terms. Chicago. American Association of Endodontists, 2020.
• ⁵²
  AlShwaimi, E; Purcell, P; Kawai, T; Sasaki, H; Oukka, M; Campos-Neto, A et al. Regulatory T cells in mouse periapical lesions. J Endod. 2009;35(9):1229-1233.
• ⁵³
  Pääkkönen, V; Rusanen, P; Hagström, J; Tjäderhane, L. Mature human odontoblasts express virus-recognizing toll-like receptors. Int Endod J. 2014;47(10):934-941.
• ⁵⁴
  Desai, SV; Love, RM; Rich, AM; Seymour, GJ. Toll-like receptor 2 expression in refractory periapical lesions. Int Endod J. 2011;44(10):907-916.
• ⁵⁵
  Matsushima, N; Tanaka, T; Enkhbayar, P; Mikami, T; Taga, M; Yamada, K; et al. Comparative sequence analysis of leucine-rich repeats (LRRs) within vertebrate toll-like receptors. BMC Genomics. 2007;8:124.
• ⁵⁶
  Bertasso, AS; Léon, JE; Silva, RAB; Silva, L; de Queiroz, AM; Pucinelli CM et al. Immunophenotypic quantification of M1 and M2 macrophage polarization in radicular cysts of primary and permanent teeth. Int Endod J. 2020;53(5):627-635.
• ⁵⁷
  da Rosa, WLO; Piva, E; da Silva, AF. Disclosing the physiology of pulp tissue for vital pulp therapy. Int Endod J. 2018;51(8):829-846.
• ⁵⁸
  Giraud, T; Jeanneau, C; Rombouts, C; Bakhtiar, H; Laurent, P; About, I. Pulp capping materials modulate the balance between inflammation and regeneration. Dent Mater. 2019;35(1):24-35.
• ⁵⁹
  Iwasaki, A; Medzhitov, R. Regulation of adaptive immunity by the innate immune system. Science. 2010;327(5963):291-295.
• ⁶⁰
  Linehan, E; Fitzgerald, DC. Ageing and the immune system: focus on macrophages. Eur J Microbiol Immunol(Bp). 2015;5(1):14-24.
• ⁶¹
  Clària, J. Cyclooxygenase-2 biology. Curr Pharm Des. 2003;9(27):2177-2190.
• ⁶²
  Robbins, SL; Kumar, V; Cotran, RS. (2010). Robbins and Cotran pathologic basis of disease. 8th ed. Philadelphia, PA: Saunders/Elsevier.
• ⁶³
  Pidgeon, GP; Lysaght, J; Krishnamoorthy, S; Reynolds, JV; O'Byrne, K Ni D; et al. Lipoxygenase metabolism: roles in tumor progression and survival. Cancer Metastasis Rev. 2007;26(3-4):503-524.
• ⁶⁴
  Thomas, MV; Puleo, DA. Infection, inflammation, and bone regeneration: a paradoxical relationship. J Dent Res. 2011;90(9):1052-1061.
• ⁶⁵
  Alexander, WS. Suppressors of cytokine signalling (SOCS) in the immune system. Nat Rev Immunol. 2002;2(6):410-416.
• ⁶⁶
  Alexander, WS; Hilton, DJ. The role of suppressors of cytokine signaling (SOCS) proteins in regulation of the immune response. Annu Rev Immunol. 2004;22:503-529.
• ⁶⁷
  Larsen, L; Röpke, C. Suppressors of cytokine signalling: SOCS. APMIS. 2002;110(12):833-844.
• ⁶⁸
  Oppenheim, JJ; Neta, R. Pathophysiological roles of cytokines in development, immunity, and inflammation. FASEB J. 1994;8(2):158-162.
• ⁶⁹
  Tani-Ishii, N; Wang, CY; Stashenko, P. Immunolocalization of bone-resorptive cytokines in rat pulp and periapical lesions following surgical pulp exposure. Oral Microbiol Immunol. 1995;10(4):213-219.
• ⁷⁰
  Fouad, AF. IL-1 alpha and TNF-alpha expression in early periapical lesions of normal and immunodeficient mice. J Dent Res. 1997;76(9):1548-1554.
• ⁷¹
  Matsuo, T; Ebisu, S; Nakanishi, T; Yonemura, K; Harada, Y; Okada, H. Interleukin-1 alpha and interleukin-1 beta periapical exudates of infected root canals: correlations with the clinical findings of the involved teeth. J Endod. 1994;20(9):432-435.
• ⁷²
  Ataoğlu, T; Ungör, M; Serpek, B; Haliloğlu, S; Ataoğlu, H; Ari ,H. Interleukin-1beta and tumour necrosis factor-alpha levels in periapical exudates. Int Endod J. 2002;35(2):181-185.
• ⁷³
  Hirano, T; Matsuda, T; Nakajima, K. Signal transduction through gp130 that is shared among the receptors for the interleukin 6 related cytokine subfamily. Stem Cells. 1994;12(3):262-277. doi:10.1002/stem.5530120303
  » https://doi.org/10.1002/stem.5530120303
• ⁷⁴
  Van, Damme, J; Opdenakker, G. Interaction of interferons with skin reactive cytokines: from interleukin-1 to interleukin-8. J Invest Dermatol. 1990;95(6 Suppl):90S-93S.
• ⁷⁵
  Dumoutier, L; Louahed, J; Renauld, JC. Cloning and characterization of IL-10-related T cell-derived inducible factor (IL-TIF), a novel cytokine structurally related to IL-10 and inducible by IL-9. J Immunol. 2000;164(4):1814-1819.
• ⁷⁶
  Zenewicz, LA; Flavell, RA. Recent advances in IL-22 biology. Int Immunol. 2011;23(3):159-163.
• ⁷⁷
  Liang, SC; Tan, XY; Luxenberg, DP; Karin, R; Dunussi-Joannopoulos, K; Collins, M; et al. Interleukin (IL)-22 and IL-17 are coexpressed by Th17 cells and cooperatively enhance expression of antimicrobial peptides. J Exp Med. 2006;203(10):2271-2279. doi:10.1084/jem.20061308
  » https://doi.org/10.1084/jem.20061308
• ⁷⁸
  Dumoutier, L; Van Roost, E; Cola, D; Renauld, JC. Human interleukin-10-related T cell-derived inducible factor: molecular cloning and functional characterization as an hepatocyte-stimulating factor. Proc Natl Acad Sci U S A. 2000;97(18):10144-10149.
• ⁷⁹
  Wolk, K; Witte, E; Wallace, E; Döcke, WD; Kunz,, S; Asadullah K; et al. IL-22 regulates the expression of genes responsible for antimicrobial defense, cellular differentiation, and mobility in keratinocytes: a potential role in psoriasis. Eur J Immunol. 2006;36(5):1309-1323.
• ⁸⁰
  Liang, SC; Nickerson-Nutter, C; Pittman, DD; Carrier, Y; Goodwin DG; Shields, K. et al. IL-22 induces an acute-phase response. J Immunol. 2010;185(9):5531-5538.
• ⁸¹
  Nickoloff, BJ. Cracking the cytokine code in psoriasis. Nat Med. 2007;13(3):242-244.
• ⁸²
  Cheng, F; Guo, Z; Xu, H; Yan, D; Li, Q. Decreased plasma IL22 levels, but not increased IL17 and IL23 levels, correlate with disease activity in patients with systemic lupus erythematosus. Ann Rheum Dis. 2009;68(4):604-606.
• ⁸³
  Geboes, L; Dumoutier, L; Kelchtermans, H; Schurgers,, E; Mitera T; Renauld, JC; et al. Proinflammatory role of the Th17 cytokine interleukin-22 in collagen-induced arthritis in C57BL/6 mice. Arthritis Rheum. 2009;60(2):390-395.
• ⁸⁴
  Fujita, H; Nograles, KE; Kikuchi, T; Gonzalez, J; Carucci, JA; Krueger, JG. Human Langerhans cells induce distinct IL-22-producing CD4+ T cells lacking IL-17 production. Proc Natl Acad Sci U S A. 2009;106(51):21795-21800.
• ⁸⁵
  Sonnenberg, GF; Fouser, LA; Artis, D. Border patrol: regulation of immunity, inflammation and tissue homeostasis at barrier surfaces by IL-22. Nat Immunol. 2011;12(5):383-390.
• ⁸⁶
  Nograles, KE; Zaba, LC; Shemer, A; Fuentes-Duculan, J; Cardinale, I; Kikuchi ,T; et al. IL-22-producing "T22" T cells account for upregulated IL-22 in atopic dermatitis despite reduced IL-17-producing TH17 T cells. J Allergy Clin Immunol. 2009;123(6):1244-52.e2.
• ⁸⁷
  de Oliveira, KM; da Silva, RA; De Rossi, A; Fukada, SY; Feres, M; Nelson-Filho, P; et al. Absence of interleukin 22 affects the oral microbiota and the progression of induced periapical lesions in murine teeth. Int Endod J. 2015;48(1):46-59.
• ⁸⁸
  Starr, R; Willson, TA; Viney, EM; Murray, LJ; Rayner, JR; Jenkins, BJ; et al. A family of cytokine-inducible inhibitors of signalling. Nature. 1997;387(6636):917-921.
• ⁸⁹
  Menezes R; Garlet TP; Letra A ; Bramante, CM; Campanelli, AP; Figueira, R; et al. Differential patterns of receptor activator of nuclear factor kappa B ligand/osteoprotegerin expression in human periapical granulomas: possible association with progressive or stable nature of the lesions. J Endod. 2008;34(8):932-938.
• ⁹⁰
  Fukushima, A; Kajiya, H; Izumi, T; Shigeyama, C; Okabe, K; Anan, H Pro-inflammatory cytokines induce suppressor of cytokine signaling-3 in human periodontal ligament cells. J Endod. 2010;36(6):1004-1008.
• ⁹¹
  de Andrés, MC; Imagawa, K; Hashimoto, K; Gonzalez, A; Goldring, MB; Roach, HI; et al. Suppressors of cytokine signalling (SOCS) are reduced in osteoarthritis. Biochem Biophys Res Commun. 2011;407(1):54-59. Suppressors of cytokine signalling (SOCS) are reduced in osteoarthritis. Biochem Biophys Res Commun. 2011;407(1):54-59.
• ⁹²
  de Souza, JA; Nogueira, AV; de Souza, PP; Cirelli, JA; Garlet GP ; Rossa, C Jr. Expression of suppressor of cytokine signaling 1 and 3 in ligature-induced periodontitis in rats. Arch Oral Biol. 2011;56(10):1120-1128.
• ⁹³
  Chaves de Souza, JA; Nogueira, AV; Chaves de Souza, PP; Kim YJ; Silva Lobo, C; Pimentel Lopes de Oliveira, G. J.; et al. SOCS3 expression correlates with severity of inflammation, expression of proinflammatory cytokines, and activation of STAT3 and p38 MAPK in LPS-induced inflammation in vivo. Mediators Inflamm. 2013;650812.
• ⁹⁴
  Wang, SM; Ma, N; Qiu, LH; Li XL; Yang D; Xue M. Expression of SOCS-1 and SOCS-3 in chronic periapical lesions and its clinical significance Shanghai Kou Qiang Yi Xue. 2017;26(4):384-388.
• ⁹⁵
  Boyce, BF. Advances in the regulation of osteoclasts and osteoclast functions. J Dent Res. 2013;92(10):860-867.
• ⁹⁶
  Andrucioli, M; Matsumoto, M; Fukada SY; Saraiva, M; Bergamo, A; Romano FL; et al. Quantification of pro-inflammatory cytokines and osteoclastogenesis markers in successful and failed orthodontic mini-implants. J Appl Oral Sci. 2019;27:e20180476.
• ⁹⁷
  Wang, Z; McCauley, LK. Osteoclasts and odontoclasts: signaling pathways to development and disease. Oral Dis. 2011;17(2):129-142.
• ⁹⁸
  Cavalla, F; Letra A ; Silva RM ; Garlet GP. Determinants of Periodontal/Periapical Lesion Stability and Progression. J Dent Res. 2021;100(1):29-36.
• ⁹⁹
  Rochefor,t GY; Pallu, S; Benhamou, CL. Osteocyte: the unrecognized side of bone tissue. Osteoporos Int. 2010;21(9):1457-1469.
• ¹⁰⁰
  Dallas, SL; Prideaux, M; Bonewald, LF. The osteocyte: an endocrine cell ... and more. Endocr Rev. 2013;34(5):658-690.
• ¹⁰¹
  Schaffler, MB; Kennedy, OD. Osteocyte signaling in bone. Curr Osteoporos Rep. 2012;10(2):118-125.
• ¹⁰²
  Atkins, GJ; Findlay, DM. Osteocyte regulation of bone mineral: a little give and take. Osteoporos Int. 2012;23(8):2067-2079.
• ¹⁰³
  Tresguerres, FGF; Torres, J; López-Quiles, J; Hernández, G; Vega, JA; Tresguerres, IF. The osteocyte: A multifunctional cell within the bone [published correction appears in Ann Anat. 2020 Jul;230:151510]. Ann Anat. 2020;227:151422.
• ¹⁰⁴
  Kramer, I; Halleux, C; Keller, H; et al. Osteocyte Wnt/beta-catenin signaling is required for normal bone homeostasis. Mol Cell Biol. 2010;30(12):3071-3085.
• ¹⁰⁵
  Garlet GP ; Cardoso CR; Silva, TA; Ferreira, BR; Avila-Campos, MJ; Cunha, FQ; et al. Cytokine pattern determines the progression of experimental periodontal disease induced by Actinobacillus actinomycetemcomitans through the modulation of MMPs, RANKL, and their physiological inhibitors. Oral Microbiol Immunol. 2006;21(1):12-20.
• ¹⁰⁶
  Herrera, H; Herrera, H; Leonardo, MR; de Paula e Silva, FW; da Silva, LA. Treatment of external inflammatory root resorption after autogenous tooth transplantation: case report. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2006;102(6):e51-e54.
• ¹⁰⁷
  Paula-Silva, FW; da Silva, LA; Kapila, YL. Matrix metalloproteinase expression in teeth with apical periodontitis is differentially modulated by the modality of root canal treatment. J Endod. 2010;36(2):231-237.
• ¹⁰⁸
  Curran, S; Murray, GI. Matrix metalloproteinases: molecular aspects of their roles in tumour invasion and metastasis. Eur J Cancer. 2000;36(13 Spec No):1621-1630.
• ¹⁰⁹
  Coussens, PM; Colvin, CJ; Wiersma, K; Abouzied, A; Sipkovsky, S. Gene expression profiling of peripheral blood mononuclear cells from cattle infected with Mycobacterium paratuberculosis. Infect Immun. 2002;70(10):5494-5502.
• ¹¹⁰
  Sorsa, T; Mäntylä, P; Tervahartiala, T; Pussinen PJ; Gamonal, J; Hernandez, M. MMP activation in diagnostics of periodontitis and systemic inflammation. J Clin Periodontol. 2011;38(9):817-819.
• ¹¹¹
  Santos, S; Couto, LA; Fonseca, JM; Xavier, F; Figueiredo, A ; Freitas, VS; et al. Participation of osteoclastogenic factors in immunopathogenesis of human chronic periapical lesions. J Oral Pathol Med. 2017;46(9):846-852.
• ¹¹²
  Shah, A; Lee, D; Song, M; Kim, S; Kang, MK; Kim, RH. Clastic cells are absent around the root surface in pulp-exposed periapical periodontitis lesions in mice. Oral Dis. 2018;24(1-2):57-62.
• ¹¹³
  de Paula-Silva, FW; D'Silva, NJ; da Silva, LA; Kapila, YL. High matrix metalloproteinase activity is a hallmark of periapical granulomas. J Endod. 2009;35(9):1234-1242.
• ¹¹⁴
  Stashenko, P. Role of immune cytokines in the pathogenesis of periapical lesions. Endod Dent Traumatol. 1990;6(3):89-96.
• ¹¹⁵
  Bezerra da Silva, RA; Nelson-Filho, P; Lucisano, MP; De Rossi, A; de Queiroz, AM; Bezerra da Silva, LA. MyD88 knockout mice develop initial enlarged periapical lesions with increased numbers of neutrophils. Int Endod J. 2014;47(7):675-686.
• ¹¹⁶
  Paula-Silva, F; Arnez, MFM; Petean, IBF; Almeida-Junior LA; da Silva, RAB, da Silva, LAB; et al. Effects of 5-lipoxygenase gene disruption on inflammation, osteoclastogenesis and bone resorption in polymicrobial apical periodontitis. Arch Oral Biol. 2020;112:104670.
• ¹¹⁷
  Martinho, FC; Chiesa, WM; Leite, FR; Cirelli, JA; Gomes, BP. Antigenicity of primary endodontic infection against macrophages by the levels of PGE(2) production. J Endod. 2011;37(5):602-607.
• ¹¹⁸
  Shimauchi, H; Takayama, S; Miki, Y; Okada, H. The change of periapical exudate prostaglandin E2 levels during root canal treatment. J Endod. 1997;23(12):755-758.
• ¹¹⁹
  Paula-Silva, FW; Ghosh, A; Silva, LA; Kapila, YL. TNF-alpha promotes an odontoblastic phenotype in dental pulp cells. J Dent Res. 2009;88(4):339-344.
• ²⁰
  Nikolic, N; Jakovljevic, A; Carkic, J; Beljic-Ivanovic, K; Miletic, M; Soldatovic, I; et al. Notch Signaling Pathway in Apical Periodontitis: Correlation with Bone Resorption Regulators and Proinflammatory Cytokines. J Endod. 2019;45(2):123-128.
• ¹²¹
  De Rossi, A; De Rossi, M. Mecanismos Celulares e Moleculares Envolvidos na Reabsorção Radicular Fisiológica de Dentes Decíduos. Pesquisa Brasileira em Odontopediatria e Clínica Integrada. 2010; 505-11.
• ¹²²
  Samoto, H; Shimizu ,E; Matsuda-Honjo, Y; Saito, R; Yamazaki, M; Kasai, K; et al. TNF-alpha suppresses bone sialoprotein (BSP) expression in ROS17/2.8 cells. J Cell Biochem. 2002;87(3):313-323.
• ¹²³
  De Rossi, P; Harde, E; Dupuis, JP; Martin ,L; Chounlamountri, N; Bardin, M; et al. Co-activation of VEGF and NMDA receptors promotes synaptic targeting of AMPA receptors. Mol Psychiatry. 2016;21(12):1647.
• ¹²⁴
  Pedro, FM; Marques, A; Pereira, TM; Bandeca, MC; Lima, S; Kuga, MC; et al. Status of Endodontic Treatment and the Correlations to the Quality of Root Canal Filling and Coronal Restoration. J Contemp Dent Pract. 2016;17(10):830-6.
• ¹²⁵
  Alghofaily, M; Tordik, P; Romberg, E; Martinho, F; Fouad AF. Healing of Apical Periodontitis after Nonsurgical Root Canal Treatment: The Role of Statin Intake. J Endod. 2018;44(9):1355-60.
• ¹²⁶
  Barreiros, D; Pucinelli, CM; Oliveira, K; Paula-Silva, F; Nelson Filho, P; Silva, L; et al. Immunohistochemical and mRNA expression of RANK, RANKL, OPG, TLR2 and MyD88 during apical periodontitis progression in mice. J Appl Oral Sci. 2018;26:e20170512.
• ¹²⁷
  Dessaune, Neto N; Porpino, M; Antunes, H; Rodrigues, R; Perez, AR; Pires, FR; et al. Pro-inflammatory and anti-inflammatory cytokine expression in post-treatment apical periodontitis. J Appl Oral Sci. 2018;26:e20170455.
• ¹²⁸
  Fouad, AF; Khan, AA; Silva, RM; et al(2020) Genetic and Epigenetic Characterization of Pulpal and Periapical Inflammation. Frontiers in Physiology 4;11:21.
• ¹²⁹
  Wohlrab, H. The human mitochondrial transport/carrier protein family. Nonsynonymous single nucleotide polymorphisms (nsSNPs) and mutations that lead to human diseases. Biochim Biophys Acta. 2006;1757(9-10):1263-1270.
• ³⁰
  Hoffmann, SC; Stanley, EM; Cox, ED; DiMercurio, BS; Kozio,l DE; Harlan, DM; et al. Ethnicity greatly influences cytokine gene polymorphism distribution. Am J Transplant. 2002;2(6):560-567.
• ¹³¹
  Ghareeb, D; Abdelazem, AS; Hussein, EM; et al (2021) Association of TNF-α-308 G>A (rs1800629) polymorphism with susceptibility of metabolic syndrome. Journal of Diabetes & Metabolic Disorders13;20(1), 209-15.
• ¹³²
  González-Navarro, B; Segura-Egea ,JJ; Estrugo-Devesa, A; et al (2020) Relationship between Apical Periodontitis and Metabolic Syndrome and Cardiovascular Events: A Cross-Sectional Study. Journal of Clinical Medicine 4;9(10):3205.
• ¹³³
  Kamdee, K; Panadsako, N; Mueangson, O; et al (2021) Promoter polymorphism of TNF-α (rs1800629) is associated with ischemic stroke susceptibility in a southern Thai population. Journal of Biomedical Science 15(3):78.
• ¹³⁴
  Shi, LX; Zhang, L; Zhang, DL; et al (2021) Association between TNF-α G-308A (rs1800629) polymorphism and susceptibility to chronic periodontitis and type 2 diabetes mellitus: A meta-analysis. Journal of Periodontal Research 56(2), 226-35.
• ¹³⁵
  Jakovljevic A; Jacimovic J; Georgiou AC; et al (2022) Single nucleotide polymorphisms as a predisposing factor for the development of apical periodontitis-An umbrella review. International Endodontic Journal 55(7):700-13.

Publication Dates

• Publication in this collection
  26 Aug 2022
• Date of issue
  Jul-Aug 2022

History

• Received
  24 June 2022
• Accepted
  03 Aug 2022